World EPA Congress 2026

World EPA Congress sets the global agenda for healthcare evidence, pricing and access

The World EPA Congress is recognized as a world-leading platform dedicated to healthcare evidence, pricing, and access. At a time when healthcare systems are under growing pressure from rising costs, demographic change, and rapid innovation, the congress brings clarity to some of the most complex questions facing the industry today. It serves as a meeting point for decision-makers who shape how medicines and therapies reach patients across global markets.

Focused on evidence-driven decision-making, the World EPA Congress connects science, policy, and strategy. It addresses the full spectrum of challenges surrounding market access and reimbursement, while keeping patient outcomes at the center of discussion. By combining strategic insight with practical expertise, the congress helps organizations navigate an increasingly demanding healthcare environment.

More than a conference, the World EPA Congress functions as a working forum for alignment between stakeholders who influence healthcare value.

A comprehensive focus on market access, pricing and reimbursement

One of the defining strengths of the World EPA Congress is its holistic approach. The event covers the full lifecycle of healthcare evidence and access, reflecting how interconnected these topics have become. Discussions move beyond theory and focus on how pricing and reimbursement decisions are made in real-world settings.

Core areas of focus include

• Market access strategy across global and regional markets
• Pricing models and value-based approaches
• Reimbursement pathways and payer expectations
• Health technology assessments and decision frameworks

These themes are explored through practical case studies, expert panels, and strategic sessions. Participants gain insight into how evidence is evaluated, how value is demonstrated, and how access strategies can be adapted to diverse healthcare systems.

By addressing both mature and emerging markets, the congress offers a truly global perspective.

Advancing healthcare through evidence and outcomes research

Evidence lies at the heart of sustainable healthcare decisions, and the World EPA Congress places strong emphasis on its generation and application. Health economics and outcomes research play a critical role in demonstrating value, informing policy, and supporting patient-centered care.

Key topics explored include

• Real-world evidence and its role in decision-making
• Health economics models supporting value demonstration
• Outcomes research aligned with payer and patient needs

These discussions highlight how robust data can bridge the gap between innovation and access. By aligning clinical, economic, and real-world perspectives, stakeholders can better support informed, transparent decisions that benefit healthcare systems and patients alike.

Addressing rare diseases and specialized healthcare challenges

Rare diseases represent one of the most complex areas of modern healthcare, and the World EPA Congress dedicates focused attention to this field. The challenges of limited patient populations, high development costs, and evolving regulatory expectations require tailored approaches to pricing and access.

The congress provides a platform for dialogue on

• Innovative access models for rare and orphan diseases
• Evidence generation in small populations
• Collaboration between manufacturers, payers, and patient groups

These conversations recognize that traditional frameworks often fall short when applied to rare diseases. By sharing experience and best practices, participants contribute to more flexible, patient-focused solutions.

Connecting solution providers with healthcare decision-makers

With more than 120 leading solution providers participating, the World EPA Congress offers direct access to expertise across the healthcare value chain. These organizations support operational excellence in areas such as evidence generation, market access execution, pricing strategy, and data analytics.

Participants benefit from engaging with providers specializing in

• Evidence and data solutions
• Market access consulting and implementation
• Pricing and reimbursement analytics
• Rare disease strategy and support

This ecosystem allows attendees to identify partners who can help translate strategy into execution. The emphasis is not only on ideas, but on actionable solutions that deliver measurable impact.

A global forum shaping the future of healthcare access

The World EPA Congress stands out for its ability to bring together diverse perspectives in a structured and collaborative environment. Industry leaders, policymakers, payers, researchers, and solution providers engage in open dialogue aimed at improving healthcare access while ensuring system sustainability.

By combining thought leadership with practical expertise, the congress helps shape future standards in evidence, pricing, and access. It reinforces the importance of collaboration in a landscape where no single stakeholder can address challenges alone.

For professionals seeking to stay ahead of evolving healthcare expectations, the World EPA Congress remains an essential event a place where evidence meets strategy, access meets innovation, and the future of global healthcare takes form.